BioLineRx Ltd. Files 20-F for FY2024
Ticker: BLRX · Form: 20-F · Filed: Mar 31, 2025 · CIK: 1498403
Sentiment: neutral
Topics: 20-F, annual-report, licensing-agreement
TL;DR
BioLineRx dropped its 20-F for 2024 - check out the Gloria License and Purchase Agreements.
AI Summary
BioLineRx Ltd. filed its 20-F for the fiscal year ending December 31, 2024. The filing details its business operations, financial performance, and risk factors. Key agreements mentioned include the Gloria License Agreement and Purchase Agreement, with specific dates and terms related to licensing and performance obligations.
Why It Matters
This filing provides investors with a comprehensive overview of BioLineRx's financial health and strategic direction for the past fiscal year, crucial for investment decisions.
Risk Assessment
Risk Level: medium — The filing contains standard disclosures for a foreign private issuer, including business risks and financial information, but lacks specific forward-looking financial projections that would indicate a higher risk.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the 20-F filing.)
- 2025-03-31 — Filing Date (The date the 20-F was submitted to the SEC.)
Key Players & Entities
- BioLineRx Ltd. (company) — Filer of the 20-F report
- Gloria License Agreement (company) — Key agreement mentioned in the filing
- Gloria Purchase Agreement (company) — Key agreement mentioned in the filing
FAQ
What is the primary business of BioLineRx Ltd. as described in the 20-F?
The filing indicates BioLineRx Ltd. operates in the Pharmaceutical Preparations industry (SIC code 2834).
What are the key agreements highlighted in the filing?
The filing mentions the 'Gloria License Agreement' and 'Gloria Purchase Agreement', with associated dates and member types like 'MinimumMember' and 'MaximumMember'.
What is the fiscal year end for BioLineRx Ltd. reported in this 20-F?
The fiscal year end reported is December 31, 2024.
What is the SEC file number for BioLineRx Ltd.?
The SEC file number is 001-35223.
Where is BioLineRx Ltd. headquartered?
BioLineRx Ltd.'s business address is 2 HAMA-AYAN STREET, MODI-IN TECHNOLOGY PARK, MODI-IN, L3, 7177871.
Filing Details
This Form 20-F (Form 20-F) was filed with the SEC on March 31, 2025 regarding BioLineRx Ltd. (BLRX).